34 related articles for article (PubMed ID: 24460965)
1. Molecular description of flexibility in an antibody combining site.
Zimmermann J; Romesberg FE; Brooks CL; Thorpe IF
J Phys Chem B; 2010 Jun; 114(21):7359-70. PubMed ID: 20455589
[TBL] [Abstract][Full Text] [Related]
2. Expression of combinatorial immunoglobulins in macrophages in the tumor microenvironment.
Fuchs T; Hahn M; Ries L; Giesler S; Busch S; Wang C; Han J; Schulze TJ; Puellmann K; Beham AW; Kaminski WE; Neumaier M
PLoS One; 2018; 13(9):e0204108. PubMed ID: 30240437
[TBL] [Abstract][Full Text] [Related]
3. Joined at the hip: The role of light chain complementarity determining region 2 in antibody self-association.
Sargunas PR; Spangler JB
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2208330119. PubMed ID: 35776537
[No Abstract] [Full Text] [Related]
4. An in silico method to assess antibody fragment polyreactivity.
Harvey EP; Shin JE; Skiba MA; Nemeth GR; Hurley JD; Wellner A; Shaw AY; Miranda VG; Min JK; Liu CC; Marks DS; Kruse AC
Nat Commun; 2022 Dec; 13(1):7554. PubMed ID: 36477674
[TBL] [Abstract][Full Text] [Related]
5. Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune.
Timofeeva AM; Sedykh SE; Ermakov EA; Matveev AL; Odegova EI; Sedykh TA; Shcherbakov DN; Merkuleva IA; Volosnikova EA; Nesmeyanova VS; Tikunova NV; Nevinsky GA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430159
[TBL] [Abstract][Full Text] [Related]
6. The Blood of the HIV-Infected Patients Contains κ-IgG, λ-IgG, and Bispecific κλ-IgG, Which Possess DNase and Amylolytic Activity.
Timofeeva A; Sedykh S; Maksimenko L; Sedykh T; Skudarnov S; Ostapova T; Yaschenko S; Gashnikova N; Nevinsky G
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207591
[TBL] [Abstract][Full Text] [Related]
7. Drivers and regulators of humoral innate immune responses to infection and cancer.
Kumar D; Romero Y; Schuck KN; Smalley H; Subedi B; Fleming SD
Mol Immunol; 2020 May; 121():99-110. PubMed ID: 32199212
[TBL] [Abstract][Full Text] [Related]
8. Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer's Disease.
Hromadkova L; Ovsepian SV
J Immunol Res; 2019; 2019():7406810. PubMed ID: 31687413
[TBL] [Abstract][Full Text] [Related]
9. Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals.
Patel P; Kearney JF
J Immunol; 2016 Dec; 197(11):4201-4209. PubMed ID: 27864551
[TBL] [Abstract][Full Text] [Related]
10. Antibody polyreactivity in health and disease: statu variabilis.
Dimitrov JD; Planchais C; Roumenina LT; Vassilev TL; Kaveri SV; Lacroix-Desmazes S
J Immunol; 2013 Aug; 191(3):993-9. PubMed ID: 23873158
[TBL] [Abstract][Full Text] [Related]
11. Homogeneous (monoclonal) immunoglobulins in cancer.
Solomon A
Am J Med; 1977 Aug; 63(2):169-76. PubMed ID: 70169
[No Abstract] [Full Text] [Related]
12. Polyreactivity of natural antibodies: exchange by HL-fragments.
Sedykh MA; Buneva VN; Nevinsky GA
Biochemistry (Mosc); 2013 Dec; 78(12):1305-20. PubMed ID: 24460965
[TBL] [Abstract][Full Text] [Related]
13. Half molecular exchange of IgGs in the blood of healthy humans: chimeric lambda-kappa-immunoglobulins containing HL fragments of antibodies of different subclasses (IgG1-IgG4).
Sedykh SE; Lekchnov EA; Prince VV; Buneva VN; Nevinsky GA
Mol Biosyst; 2016 Oct; 12(10):3186-95. PubMed ID: 27506137
[TBL] [Abstract][Full Text] [Related]
14. Human milk sIgA molecules contain various combinations of different antigen-binding sites resulting in a multiple binding specificity of antibodies and enzymatic activities of abzymes.
Sedykh SE; Buneva VN; Nevinsky GA
PLoS One; 2012; 7(11):e48756. PubMed ID: 23133657
[TBL] [Abstract][Full Text] [Related]
15. Human placenta: relative content of antibodies of different classes and subclasses (IgG1-IgG4) containing lambda- and kappa-light chains and chimeric lambda-kappa-immunoglobulins.
Lekchnov EA; Sedykh SE; Dmitrenok PS; Buneva VN; Nevinsky GA
Int Immunol; 2015 Jun; 27(6):297-306. PubMed ID: 25644595
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
